BerGenBio ASA (BRRGF)
USD 2.5
(0.0%)
USD 2.5
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -15.31 Million USD | 0.2% |
| 2022 | -15.34 Million USD | 68.85% |
| 2021 | -49.26 Million USD | 41.38% |
| 2020 | -84.04 Million USD | -191.92% |
| 2019 | -28.79 Million USD | 30.82% |
| 2018 | -41.61 Million USD | 2.74% |
| 2017 | -42.79 Million USD | -156.15% |
| 2016 | -16.7 Million USD | -144.21% |
| 2015 | -6.84 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -10.84 Million USD | 24.56% |
| 2024 Q2 | -18.72 Million USD | -70.53% |
| 2023 Q1 | -6.9 Million USD | 55.0% |
| 2023 Q2 | -21.02 Million USD | -204.55% |
| 2023 FY | -15.31 Million USD | 0.2% |
| 2023 Q3 | -15.8 Million USD | 24.83% |
| 2023 Q4 | -15.31 Million USD | 3.11% |
| 2022 Q2 | -29.4 Million USD | 29.43% |
| 2022 FY | -15.34 Million USD | 68.85% |
| 2022 Q4 | -15.34 Million USD | 25.76% |
| 2022 Q3 | -20.67 Million USD | 29.7% |
| 2022 Q1 | -41.66 Million USD | 15.43% |
| 2021 Q1 | -77.09 Million USD | 0.0% |
| 2021 Q4 | -49.26 Million USD | 15.15% |
| 2021 Q3 | -58.06 Million USD | 12.76% |
| 2021 Q2 | -66.56 Million USD | 13.66% |
| 2021 FY | -49.26 Million USD | 41.38% |
| 2020 FY | -84.04 Million USD | -191.92% |
| 2019 FY | -28.79 Million USD | 30.82% |
| 2018 FY | -41.61 Million USD | 2.74% |
| 2017 FY | -42.79 Million USD | -156.15% |
| 2016 FY | -16.7 Million USD | -144.21% |
| 2015 FY | -6.84 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 197.162% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 471.916% |
| SQZ Biotechnologies Company | -36.23 Million USD | 57.736% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 135.79% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | -142.93% |
| Mesoblast Limited | 55.85 Million USD | 127.419% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 1751.836% |
| Genus plc | 190.6 Million USD | 108.035% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 785.006% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 1361.697% |
| Marizyme, Inc. | 18.56 Million USD | 182.479% |
| ContraFect Corporation | -6.02 Million USD | -154.159% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 2352.293% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 11475.303% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 1425.533% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 783.051% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 378.369% |
| MultiCell Technologies, Inc. | 90.04 USD | 17009866.77% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -1986.656% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 218.304% |
| EV Biologics, Inc. | 1.36 Million USD | 1219.585% |
| Q BioMed Inc. | 4.06 Million USD | 477.231% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 150.126% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 2560.874% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 1619.832% |
| Biomind Labs Inc. | 711.4 Thousand USD | 2252.875% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 109.8 Million USD | 113.948% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 219.592% |
| Skye Bioscience, Inc. | -5.72 Million USD | -167.69% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 1880.384% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 11055.047% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 371.151% |
| IMV Inc. | 7.67 Million USD | 299.668% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 77190.623% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 795.537% |
| GB Sciences, Inc. | 1.74 Million USD | 976.521% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -8233.294% |
| HST Global, Inc. | 96.79 Thousand USD | 15923.039% |
| CSL Limited | 10.52 Billion USD | 100.146% |
| Halberd Corporation | 144.72 Thousand USD | 10682.841% |
| Enzolytics Inc. | 981.65 Thousand USD | 1660.179% |
| Resverlogix Corp. | 6.45 Million USD | 337.414% |
| Affymax, Inc. | -5.59 Million USD | -173.639% |
| SYBLEU INC | 473.71 Thousand USD | 3333.089% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -2175.419% |
| argenx SE | -2.02 Billion USD | 99.245% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 135.262% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 67.422% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 665.44% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | -73.255% |
| AVAX Technologies, Inc. | -5.9 Million USD | -159.445% |
| Zenith Capital Corp. | 10.06 Thousand USD | 152281.975% |
| Genscript Biotech Corporation | -1.06 Billion USD | 98.557% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 7741.292% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 741.885% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 9409.882% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 125.296% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 866.013% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -2.57 Million USD | -495.93% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 4357.762% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 175.536% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -83509.532% |
| BioStem Technologies, Inc. | 4.47 Million USD | 442.477% |
| ONE Bio Corp. | 9.04 Million USD | 269.42% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 7710.082% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -1169029.313% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 7526.931% |
| Agentix Corp. | 37.63 Thousand USD | 40799.407% |
| LadRx Corporation | -2.03 Million USD | -652.066% |
| Cell Source, Inc. | 9.23 Million USD | 265.897% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -74947.011% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 2511.27% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 2511.27% |
| NovAccess Global Inc. | 2.17 Million USD | 803.045% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 316.598% |
| Itoco Inc. | 228.3 Thousand USD | 6808.392% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 11362.377% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 408.969% |
| Kadimastem Ltd | -253.1 Thousand USD | -5951.155% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 3911.281% |
| CytoDyn Inc. | 20.26 Million USD | 175.588% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -2367070.634% |
| Mobile Lads Corp. | 484.23 Thousand USD | 3262.863% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -165146.355% |
| Qrons Inc. | 351.42 Thousand USD | 4458.115% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 298.749% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -6035.564% |
| Rebus Holdings, Inc. | 305 Thousand USD | 5121.506% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 443.628% |
| International Stem Cell Corporation | 2.59 Million USD | 691.336% |
| Bioxytran, Inc. | 1.89 Million USD | 906.545% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 24639.109% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 802.26% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 545.999% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 279.067% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 2082.327% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -1125.248% |
| Neutra Corp. | 52.18 Thousand USD | 29447.527% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -515.331% |
| PureTech Health plc | -167.19 Million USD | 90.84% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -6153.611% |
| IXICO plc | -4.44 Million USD | -244.59% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 215.86% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 127.922% |
| CSL Limited | 10.52 Billion USD | 100.146% |
| Cellectis S.A. | -43.81 Million USD | 65.048% |